Insider · CIK 0001833453

GRAY SUSANNAH

Reports to the SEC for 6 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001833453

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.4K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−42.1K sh	—	—	6,009
2026-09-23	TBPHTheravance Biopharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,009 sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.7K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.6K sh	—	—	0
2026-09-23	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.3K sh	—	—	0
2026-06-17	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2026-06-12	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+6,009 sh	—	—	48,146
2026-06-12	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,398
2026-05-26	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director	AAward	+46.3K sh	—	—	216,200
2026-04-27	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	Director	AAward	+11.3K sh	—	—	11,250
2025-06-17	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2025-06-16	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director	AAward	+89.1K sh	$2.16	+$193K	169,907
2025-05-19	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.6K sh	—	—	42,137
2025-05-19	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+24.3K sh	—	—	24,258
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.6K sh	—	—	0
2024-08-16	Morphic Holding, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2024-06-04	Morphic Holding, Inc.Common StockA Award	Director	AAward	+23.2K sh	—	—	23,168
2024-05-23	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director	AAward	+20.6K sh	$10.78	+$223K	80,768
2024-05-21	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right To Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2024-05-08	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+23.6K sh	—	—	23,576
2024-05-08	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.5K sh	—	—	31,488
2023-07-17	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director	AAward	+24K sh	—	—	60,123
2023-06-01	Morphic Holding, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,535
2023-05-23	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2023-05-02	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+9,132 sh	—	—	20,951
2023-05-02	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+22K sh	—	—	22,044
2023-02-26	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2023-02-26	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+10.1K sh	—	—	10,131
2023-02-26	TBPHTheravance Biopharma, Inc.A Award	Director	AAward	+1,688 sh	—	—	11,819
2023-02-26	TBPHTheravance Biopharma, Inc. · Share Option (Right to Buy)A Award	Director	AAward	+4,666 sh	—	—	4,666
2022-06-08	Morphic Holding, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,550
2022-05-23	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2022-03-29	Apria, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−5,059 sh	$37.50	−$190K	0
2021-11-19	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director	AAward	+4,271 sh	—	—	36,123
2021-06-16	Morphic Holding, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2021-06-16	Morphic Holding, Inc.Director Stock Option (right to buy)A Award	Director	AAward	0 sh	—	—	0
2021-06-10	Apria, Inc.Restricted Stock UnitsA Award	Director	AAward	+5,059 sh	—	—	5,059
2021-05-17	FDMT4D Molecular Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2021-04-27	Morphic Holding, Inc.Stock Option (right to buy Common Stock)A Award	Director	AAward	+18.1K sh	—	—	18,111
2021-04-27	Morphic Holding, Inc.Stock Option (right to buy Common Stock)A Award	Director	AAward	+24K sh	—	—	24,000
2020-11-24	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.P Purchase	Director	PPurchase	+20K sh	$27.00	+$540K	31,852
2020-11-19	MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.A Award	Director	AAward	+11.9K sh	—	—	11,852

Recent filings

Accepted (ET)
Sep 244
GRAY SUSANNAH0001833453-26-000009
SEC(opens sec.gov)
Jun 184
GRAY SUSANNAH0001193125-26-276160
SEC(opens sec.gov)
Jun 164
GRAY SUSANNAH0001833453-26-000006
SEC(opens sec.gov)
May 284
GRAY SUSANNAH0001833453-26-000004
SEC(opens sec.gov)
Apr 294
GRAY SUSANNAH0001833453-26-000003
SEC(opens sec.gov)
Jun 204
GRAY SUSANNAH0000950170-25-088496
SEC(opens sec.gov)
Jun 184
GRAY SUSANNAH0001823239-25-000088
SEC(opens sec.gov)
May 214
GRAY SUSANNAH0001415889-25-014009
SEC(opens sec.gov)
Aug 204
GRAY SUSANNAH0001415889-24-021759
SEC(opens sec.gov)

Companies

Address

C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080